Objectives: To investigate patterns of early repeat prescriptions and treatment switching over an 11-year period to estimate differences in the cost of medication wastage, dispensing fees and prescriber time for short (<60 days) and long (≥60 days) prescription lengths from the perspective of the National Health Service in the United Kingdom. Setting: Retrospective, multiple cohort study of primary care prescriptions from the Clinical Practice Research Datalink. Participants: Five random samples of 50,000 patients each prescribed oral drugs for (1) glucose control in type 2 diabetes mellitus (T2DM), (2) hypertension in T2DM, (3) statins (lipid management) in T2DM, (4) secondary prevention of myocardial infarction and (5) depression. Primar...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Background: Two alternative basal analogue insulin treatments are available: insulin glargine (glarg...
Objectives: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
OBJECTIVES: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
Objectives: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
Background: The National Health Service (NHS) in England spends over £9 billion on prescription medi...
BACKGROUND: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: The National Health Service (NHS) in England spends over £9 billion on prescription medi...
Objective: To investigate the relative impact of generic entry and NICE clinical guidelines on presc...
Objective: To investigate the relative impact of generic entry and National Institute for Health and...
King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA. Impact of issuing longer- versus shorter-du...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Background: Two alternative basal analogue insulin treatments are available: insulin glargine (glarg...
Objectives: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
OBJECTIVES: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
Objectives: To investigate patterns of early repeat prescriptions and treatment switching over an 11...
Background: The National Health Service (NHS) in England spends over £9 billion on prescription medi...
BACKGROUND: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
Background: The National Health Service (NHS) in England spends over £9 billion on prescription medi...
Objective: To investigate the relative impact of generic entry and NICE clinical guidelines on presc...
Objective: To investigate the relative impact of generic entry and National Institute for Health and...
King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA. Impact of issuing longer- versus shorter-du...
Background: To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged gene...
This is the author accepted manuscript. The final version is available from the publisher via the DO...
Background: Two alternative basal analogue insulin treatments are available: insulin glargine (glarg...